CSS
CRVS icon

Cubist Systematic Strategies’s Corvus Pharmaceuticals CRVS Stock Holding History

Cubist Systematic Strategies’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,026
Closed -$52.9K – 3161
2024
Q3 		$52.9K Sell
10,026
-14,338
-59% -$51.5K ﹤0.01% 2760
2024
Q2 		$44.3K Buy
+24,364
New +$45.4K ﹤0.01% 2716
2023
Q3 		– Sell
-15,552
Closed -$35.6K – 3466
2023
Q2 		$35.6K Buy
+15,552
New +$32.3K ﹤0.01% 3135
2022
Q2 		– Sell
-6,600
Closed -$11K – 4386
2022
Q1 		$11K Sell
6,600
-16,645
-72% -$30.5K ﹤0.01% 3493
2021
Q4 		$56K Buy
23,245
+3,193
+16% +$12.4K ﹤0.01% 3295
2021
Q3 		$97K Buy
+20,052
New +$59.4K ﹤0.01% 2748
2017
Q4 		– Sell
-1,914
Closed -$31K – 1937
2017
Q3 		$31K Buy
+1,914
New +$26.5K ﹤0.01% 1756
2017
Q2 		– Sell
-1,429
Closed -$30K – 1707
2017
Q1 		$30K Buy
1,429
+901
+171% +$14.1K ﹤0.01% 1523
2016
Q4 		$8K Buy
+528
New +$8.03K ﹤0.01% 1660

Other funds holding CRVS

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
SC
Samlyn Capital New York $5.82B AUM 36.3% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return